FDA Panel To Consider Moderna, J&J Boosters

The committee's advice will help the FDA determine whether to authorize the boosters.

An FDA advisory committee is meeting today to consider data on booster doses for the Moderna and Johnson & Johnson vaccines. 

The committee's advice will help the FDA determine whether to authorize the boosters. 

Joining us now is Newsy White House correspondent Kellan Howell with more.